Autoimmune Diabetes Onset Results From Qualitative Rather Than Quantitative Age-Dependent Changes in Pathogenic T-Cells
Open Access
- 1 May 2005
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (5) , 1415-1422
- https://doi.org/10.2337/diabetes.54.5.1415
Abstract
Diabetogenic T-cells can be detected in pre-diabetic nonobese diabetic (NOD) mice after transfer in NOD-SCID recipients. Here we demonstrate that 6-week-old pre-diabetic NOD mice, >2 months before disease onset, already harbor pathogenic T-cells in equal numbers to overtly diabetic animals. The delay in diabetes appearance is explained by the presence of regulatory CD4+CD25+ T-cells that control diabetogenic effectors and that are, in our hands, transforming growth factor (TGF)-β–dependent. Our present results suggest, however, that diabetes onset is only partly explained by a decline in this regulatory T-cell activity. Another major factor appears to be the progressive resistance of diabetogenic cells to TGF-β–dependent mediated inhibition. We propose that progression to overt disease correlates with the pathogenic T-cell’s escape from TGF-β–dependent T-cell–mediated regulation.Keywords
This publication has 50 references indexed in Scilit:
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003
- Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune DiabetesThe Journal of Experimental Medicine, 2002
- CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and ResponsivenessThe Journal of Experimental Medicine, 2002
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βThe Journal of Experimental Medicine, 2001
- Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouseDiabetes, 1997
- Lack of L‐selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel‐14 antibody treatmentEuropean Journal of Immunology, 1995
- Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model.The Journal of Experimental Medicine, 1995
- Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouseDiabetes, 1995
- Following a diabetogenic T cell from genesis through pathogenesisCell, 1993
- Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) miceDiabetes, 1986